Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Soichi Shibata"'
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 58:727-731
A 66-year-old woman was diagnosed with stage IVb sigmoid colon cancer. Modified FOLFOX-6 (mFOLFOX-6; levofolinate‒fluorouracil‒oxaliplatin) plus panitumumab was selected as the chemotherapeutic regimen, but she was administered a regimen without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9aa8d809930ea9240bf5edba1b190a2
https://doi.org/10.5414/cp203762
https://doi.org/10.5414/cp203762
Autor:
Yuki Takashima, Harumi Takahashi, Kazuhiko Hanada, Keisuke Iwa, Yasunori Tsukimura, Takuma Matsuo, Soichi Shibata, Hajime Matsubara
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 56:255-262
Objective This study was designed to clarify the factors affecting the efficacy, adverse events, and pharmacokinetics of fondaparinux in Japanese patients undergoing artificial knee replacement surgery. Materials and methods Fondaparinux (1.5 mg/d) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ccb31bb52f3b2071361dca35ac08b7
https://doi.org/10.5414/cp203169
https://doi.org/10.5414/cp203169
Autor:
Soichi Shibata, Harumi Takahashi, Akiyasu Baba, Koichiro Atsuda, Kei Takeshita, Hirotoshi Echizen, Hajime Matsubara
Publikováno v:
International journal of clinical pharmacology and therapeutics. 55(5)
Objective Timely dose reduction of concomitant medications is important after withdrawal of rifampicin, a CYP inducer. However, little is known about the differences in the time course of deinduction for various CYP isoforms. To clarify the time cour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ee7018a81660230c9f9bb71bc26fbd
https://pubmed.ncbi.nlm.nih.gov/28157069
https://pubmed.ncbi.nlm.nih.gov/28157069
Autor:
Masatoshi Saitoh, Yoshikazu Kobayashi, Gaku Inoue, Kazuhiro Chiba, Takatoshi Saitoh, Takamitsu Fujioka, Takahito Itoh, Soichi Shibata, Koichiro Atsuda, Shinya Abe, Hajime Matsubara, Yasunori Tsukimura, Mika Machida
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 40:396-401
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8b9155ad21bae4dff059675679b89b3
https://doi.org/10.5649/jjphcs.40.396
https://doi.org/10.5649/jjphcs.40.396
Autor:
Yuan-Tsong Chen, Hajime Matsubara, Hirotoshi Echizen, Minami Ohara, Maria Gabriella Scordo, Harumi Takahashi, Larisa H. Cavallari, Edith A. Nutescu, Roberto Padrini, Soichi Shibata, Vittorio Pengo, Ming Ta Michael Lee, Koichiro Atsuda
Publikováno v:
Pharmacogenomics. 18(2)
Aim: To clarify whether the activities of multiple CYPs associated with warfarin metabolism would be correlated with each other. Methods: Oral clearances (CLpo) of warfarin enantiomers were estimated in 378 Chinese, Caucasians and African–Americans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28e2c1068f5bc5946c2f6068745c854
https://pubmed.ncbi.nlm.nih.gov/27995809
https://pubmed.ncbi.nlm.nih.gov/27995809
Autor:
Jun Kainuma, Soichi Shibata, Shinya Abe, Takashi Shii, Mayumi Nishi, Masatoshi Saitoh, Takatoshi Saitoh, Koichiro Iwata, Koji Masubuchi, Koichiro Atsuda
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 39:558-564
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2a828b2df30e5d492d747e8b5ed494
https://doi.org/10.5649/jjphcs.39.558
https://doi.org/10.5649/jjphcs.39.558
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 30:638-641
The aim of this study was to devise a Drug Compliance Instruction Program (DCIP) for patients with type 2 diabetes taking oral hypoglycemic agents (OHA) and to assess its effectiveness. The new program was devised to improve levels of understanding a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6edc2eb57d8344055bd362e60ac6108
https://doi.org/10.5649/jjphcs.30.638
https://doi.org/10.5649/jjphcs.30.638
Autor:
Soichi Shibata, Hideaki Yoshitake, Nobuyuki Yamazaki, Yasuhiro Takeishi, Nobuyuki Kamiya, Ken-ichiro Ota
Publikováno v:
Scopus-Elsevier
The molten carbonate fuel cell (MCFC) is expected to be one of the most promising power generation systems for the coming century owing to its high efficiency, reduced quantity of air pollution, and flexibility to a variety of fuels. In this system,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9062535e2a8b3d552c4d2ec1d7a5a28
http://www.scopus.com/inward/record.url?eid=2-s2.0-0029392236&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0029392236&partnerID=MN8TOARS
